This study involves investigating the effects of a pseudoallergen-free (active) diet compared with a control (placebo) diet in the treatment of Chronic Idiopathic Urticaria (CIU) and/or Angioedema. The hypothesis is that over a four-week intervention period, the pseudoallergen-free diet will be more effective than the placebo diet in reducing the frequency and severity of CIU and/or Angioedema.

Official Title

The Efficacy of a Pseudoallergen-Free Diet in the Treatment of Chronic Idiopathic Urticaria or Angioedema: A Randomised Controlled Study.

Conditions

Urticaria, Angioedema

Study Type

Interventional

Study Design

Treatment, Randomized, Single Blind, Placebo Control, Single Group Assignment, Efficacy Study

Further Details

Primary Outcome Measures: The frequency and severity of CIU and/or angioedema (as determined via a five point rating scale) Secondary Outcome Measures: The relative use of antihistamines (ie how many, how often)

The role of dietary pseudoallergens as a trigger for CIU and/or Angioedema is a controversial subject. ‘Dietary Pseudoallergy’ refers to the mimicking of IgE symptoms (such as rash, itch and swelling) by components of food in the absence of a true IgE mediated response (as diagnosed by RAST and skin prick testing).

The pseudoallergen-free diet excludes a range of naturally occuring chemicals (including salicylates, amines and brewers yeast) in addition to a range of artifical preservatives and additives (for example sulphites and glutamates). The control diet is based on the general dietary guidelines for the management of diabetes (including the principles of healthy eating, low glycemic index choices and a reduced saturated fat intake).

Subjects recruited into the study will have a 3 month history of CIU and/or Angioedema and will be randomly assigned to either the active or control arm of the study in a single blinded fashion. All subjects will be advised to cease antihistamine medication and will receive one-on-one dietary counselling by a Dietitian. The diet to which each subject has been assigned (ie either active or placebo) is to be followed for a 4 week duration. The frequency and severity of CIU and/or Angioedema as well as adherence to the diet are to be measured on both a daily and weekly basis by the subject via the completion of a clinical score card. The results of the score cards will be collated to determine the relative effects of each diet on these conditions.

Study Start

September 2005

Eligibility & Criteria

Ages Eligible for Study:  21 Years   –   75 Years,  Genders Eligible for Study:  Both
Inclusion Criteria:

  • English Speaking
  • Aged between 21 to 75 years
  • 3 month history of Chronic Idiopathic Urticaria and/or Angioedema
  • Exclusion Criteria:

  • age <21 and >75 years
  • non english speaking
  • systemic lupus erythematosis
  • dysproteinemias
  • thyrotoxicosis
  • vasculitis
  • infection
  • Please Note: Study is not yet open for patient recruitment

    Total Enrolment

    50

    Contact Details

    Alfred Hospital, Melbourne,  Victoria,  3004,  Australia
    Kate L Connell, Masters  0061 3 9276 3063    k.connell@alfred.org.au 
    Jo Douglass, FRACP MD  0061 3 9276 3836    j.douglass@alfred.org.au 
    Kate L Connell, Masters,  Principal Investigator
    Jo Douglass, FRACP MD,  Sub-Investigator

    All content and media on the HealthEngine Blog is created and published online for informational purposes only. It is not intended to be a substitute for professional medical advice and should not be relied on as health or personal advice. Always seek the guidance of your doctor or other qualified health professional with any questions you may have regarding your health or a medical condition. Never disregard the advice of a medical professional, or delay in seeking it because of something you have read on this Website. If you think you may have a medical emergency, call your doctor, go to the nearest hospital emergency department, or call the emergency services immediately.